Artificial Intelligence (AI) in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, Natural Language Processing), Application (Medical Imaging & Diagnostics, Patient Data & Risk Analysis), End User & Region - Global Forecast to 2029
Updated on : October 23, 2024
Artificial Intelligence (AI) in Healthcare Market Size
The global AI in Healthcare market size was valued at USD 20.9 billion in 2024 and is estimated to reach USD 148.4 billion by 2029, growing at a CAGR of 48.1% during the forecast period from 2024 to 2029. The growth of AI in the healthcare market is driven by the generation of large and complex healthcare datasets, the pressing need to reduce healthcare costs, improving computing power and declining hardware costs, and the rising number of partnerships and collaborations among different domains in the healthcare sector, and growing need for improvised healthcare services due to imbalance between healthcare workforce and patients.
Artificial Intelligence (AI) in Healthcare Market Statistics Forecast to 2029
To know about the assumptions considered for the study, Request for Free Sample Report
AI in Healthcare Market Trends & Dynamics:
Driver: Generation of large and complex healthcare datasets
Generating extensive and intricate healthcare datasets is a pivotal driver for AI in the healthcare Market Size. Advanced technologies enable the accumulation of diverse patient information, from medical records to genomic data. This abundance of data catalyzes AI applications, facilitating the identification of patterns and insights crucial for diagnostics, personalized medicine, and treatment planning. Integrating big data analytics and AI promises to revolutionize healthcare processes, enhancing accuracy and efficiency. In the coming years, the impact of this data-driven approach is expected to be high, ushering in a transformative era in healthcare delivery with improved patient outcomes and streamlined operations.
Restraint: Reluctance among medical practitioners to adopt AI-based technologies.
Stemming from concerns about job displacement, skepticism regarding AI system reliability, and unease over integration into established practices, this reluctance impedes the market's growth. Addressing the challenge requires significant investments in training, contributing to a learning curve that discourages healthcare professionals. Overcoming this obstacle necessitates focused initiatives that underscore education and foster collaboration between technology developers and healthcare institutions. Such efforts are crucial for fostering understanding and acceptance, enabling the realization of AI's potential in healthcare, including enhanced diagnostics, improved treatment plans, and ultimately superior patient outcomes.
Opportunities: The growing potential of AI-based tools for elderly care
Factors such as increased life expectancy, shifting demographics, and challenges in traditional caregiving contribute to the growing potential of AI in elderly care. AI holds the transformative potential to enhance elderly care, ensuring effective and affordable solutions. Through continuous health monitoring, AI facilitates early detection of health issues, while fall detection algorithms improve safety. AI-driven medication management ensures adherence to treatment plans, and personalized care plans optimize interventions based on individual health data. Cognitive assistance and social interaction facilitated by AI contribute to mental well-being, particularly for seniors with conditions like dementia. The integration of companion robots and virtual assistants addresses loneliness.
Moreover, AI streamlines routine tasks, improving resource allocation in healthcare settings and enhancing cost efficiency. AI in elderly care represents a paradigm shift, offering proactive, personalized, and cost-effective solutions to ensure the well-being of the aging population. AI opens opportunities for more effective applications in healthcare, such as predictive analytics for disease outbreaks, personalized treatment plans based on genetic profiles, and advanced diagnostic tools that improve accuracy and speed in identifying medical conditions.
Challenge: Lack of curated healthcare data
The profound potential of AI in healthcare faces a substantial impediment – the scarcity of curated healthcare data. This bottleneck hampers AI performance, leading to inaccurate predictions and potential patient harm. Data fragmentation, privacy concerns, high costs, and expertise barriers exacerbate the challenge. For instance, in November 2023, the World Health Organization (WHO) released guidelines outlining essential regulatory considerations for applying artificial intelligence (AI) in healthcare. Emphasizing safety, efficacy, and collaboration, the document addresses risks related to AI's use of health data, advocating for robust legal and regulatory frameworks to ensure privacy and security. The guidelines highlight six critical areas for regulating AI in healthcare: transparency, risk management, external validation of data, commitment to data quality, addressing complex regulations like GDPR and HIPAA, and encouraging collaboration among stakeholders. Proposed solutions encompass standardization initiatives, public-private partnerships for responsible data sharing, synthetic data generation, and AI-powered curation tools to streamline the process. Overcoming this obstacle requires proactive measures like data standardization, collaboration, and technological advancements. Addressing specific healthcare sub-areas, exploring ethical considerations, and analyzing regulatory roles will further enrich the understanding and advancement of AI in healthcare.
Artificial Intelligence (AI) in Healthcare Market Ecosystem
Artificial Intelligence (AI) in Healthcare Market Segmentation
AI in Healthcare Market Share
The market for Software segment to hold largest market share during the forecast period.
The integration of non-procedural languages marks a transformative shift in the AI landscape of healthcare, traditionally dominated by procedural languages like Python and Java. These intuitive, declarative languages, such as SQL, offer a potential game-changer by emphasizing outcomes over step-by-step instructions. This shift democratizes AI development, enabling healthcare professionals to contribute directly, fostering collaboration, and leveraging domain expertise. Non-procedural languages enhance model explainability, streamline workflows, and focus on core clinical knowledge, promising significant segmental growth in areas like clinical decision support systems, medical imaging analysis, personalized medicine, and public health. Despite challenges, the potential benefits position non-procedural languages as a compelling avenue for advancing AI in healthcare, promising improved patient care and outcomes.
Deep learning segment in the machine learning technology to hold the largest share in the AI in Healthcare market during the forecast period.
Deep learning's transformative impact on healthcare lies in its ability to construct hierarchical representations through artificial neural networks (ANNs). These interconnected layers of neurons emulate the human brain's structure, learning from extensive datasets to extract intricate features and patterns. In medical imaging, deep learning excels in tasks like image classification, detecting diseases in X-rays and MRIs, and object segmentation for precise analysis. Natural Language Processing (NLP) enables the extraction of valuable information from clinical notes and research papers, facilitating diagnosis and drug discovery. Moreover, deep learning predicts molecular interactions in drug development and precision medicine, identifies drug targets, and tailors treatments based on individual genetic profiles. Clinical decision support, personalized healthcare plans, and predictive analytics further demonstrate the potential of deep learning.
Patient Data & Risk Analysis segment in application to hold the highest market share of the AI in Healthcare market during the forecast period.
Natural Language Processing (NLP) in healthcare enables computers to analyze, generate, and translate human language. It unlocks insights from unstructured data, streamlines tasks, empowers patients through chatbots, and enhances personalized medicine, revolutionizing healthcare delivery. Natural Language Processing (NLP) plays a pivotal role in revolutionizing patient data analysis and risk assessment within AI in healthcare. By converting unstructured text in medical records into structured data, NLP enables rapid and scalable analysis. It empowers clinicians to identify at-risk patients by detecting nuanced details often missed in structured data. For instance, in January 2023, IQVIA Inc’s (US) NLP Risk Adjustment Solution, applied by a large US healthcare payer, successfully automated, and digitalized their risk adjustment process, enhancing efficiency by over 25%. Utilizing NLP, they improved medical record reviews, enabling nurses to identify conditions more accurately and submit reimbursement claims to CMS with increased precision. The solution's clinically intelligent NLP, processing millions of records an hour, ensured high coding accuracy (>90% precision and recall), reduced review time, and provided a comprehensive audit trail for accepted ICD10-CM codes, enhancing overall risk adjustment submissions.
Patients segment to account for largest CAGR of the AI in Healthcare market during the forecast period.
Integrating artificial intelligence (AI) with smartphones and wearables is revolutionizing the healthcare landscape. This powerful combination is democratizing health data, allowing patients to actively participate in their well-being by tracking vital signs, sleep patterns, activity levels, and moods. The wealth of personal health data generated is analyzed by AI algorithms, enabling the identification of patterns, prediction of health risks, and personalization of treatment plans. This proactive and data-driven approach is reshaping healthcare, providing individuals with a deeper understanding of their health.
AI in Healthcare Market Regional Analysis
The AI in Healthcare market in the Asia Pacific is estimated to grow at a higher CAGR during the forecast period.
The factor driving the growth of the AI in healthcare Industry in the Asia Pacific region is the rise in the number of cancer patients in Asia Pacific countries. According to the report from the National Library of Medicine, in 2023, the Asia-Pacific region, home to over 60% of the global population, will account for half of all cancer cases and 58% of cancer-related deaths. Worldwide, there were 19.2 million new cancer cases and 9.9 million deaths, with the Asia-Pacific region witnessing nearly 50% of the new cases and over half of the cancer-related fatalities. These figures underscore the substantial cancer burden in the Asia-Pacific region. Given that nurses constitute more than half of the oncology healthcare workforce, acquiring new knowledge and embracing evidence-based practices is crucial for delivering efficient and effective cancer care.
Artificial Intelligence (AI) in Healthcare Market by Region
To know about the assumptions considered for the study, download the pdf brochure
Top AI in Healthcare Companies - Key Market Players:
Major vendors in the AI in healthcare companies include
- Koninklijke Philips N.V. (Netherlands),
- Microsoft (US),
- Siemens Healthineers AG (Germany),
- Intel Corporation (US),
- NVIDIA Corporation (US),
- Google Inc. (US),
- GE HealthCare Technologies Inc. (US),
- Medtronic (US),
- Micron Technology, Inc (US),
- Amazon.com Inc (US),
- Oracle (US), and Johnson & Johnson Services, Inc. (US). Apart from this, Merative (US), General Vision, Inc., (US), CloudMedx (US), Oncora Medical (US), Enlitic (US), Lunit Inc., (South Korea), Qure.ai (India), Tempus (US), COTA (US), FDNA INC. (US), Recursion (US), Atomwise (US), Virgin Pulse (US), Babylon Health (UK), MDLIVE (US), Stryker (US), Qventus (US), Sweetch (Israel), Sirona Medical, Inc. (US), Ginger (US), Biobeat (Israel) are among a few emerging companies in the AI in Healthcare market growth.
AI in Healthcare Market Report Scope :
Report Metric |
Details |
Estimated Market Size | USD 20.9 billion in 2024 |
Projected Market Size | USD 148.4 billion by 2029 |
Growth Rate | CAGR of 48.1% |
Market size available for years |
2020—2029 |
Base year |
2023 |
Forecast period |
2024—2029 |
Segments covered |
|
Geographic regions covered |
|
Companies covered |
The major players include Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers AG (Germany), Intel Corporation (US), NVIDIA Corporation (US), Google Inc. (US), GE HealthCare Technologies Inc. (US), Medtronic (US), Micron Technology, Inc (US), Amazon.com Inc (US), Oracle (US), and Johnson & Johnson Services, Inc. (US) and Others- total 33 players have been covered. |
Artificial Intelligence (AI) in Healthcare Market Highlights
This research report categorizes the AI in Healthcare market size Offering, Technology, Application, and End User, and Region.
Segment |
Subsegment |
AI in Healthcare market size, By Offering |
|
AI in Healthcare market size, By Technology: |
|
AI in Healthcare market share, By Application: |
|
AI in Healthcare market share, By End User: |
|
AI in Healthcare market share, By Region: |
|
Recent Developments in AI In Healthcare Industry :
- In October 2023, Microsoft (US) launched new data and AI solutions, Microsoft Cloud at the HLTH 2023 conference, aiming to empower healthcare organizations in unlocking insights and enhancing patient and clinician experiences. The introduced industry-specific data solutions in Microsoft Fabric provide a unified analytics platform, simplifying the integration of diverse health data sources and enabling secure access to valuable insights.
- In November 2023, Koninklijke Philips N.V., (Netherlands) collaborated with Vestre Viken Health Trust in Norway, deploying its AI Manager platform to enhance radiology workflows. The AI-enabled bone fracture application streamlined diagnoses, allowing radiologists to focus on complex cases. This initiative, spanning 30 hospitals and serving around 3.8 million people, marked Philips' most extensive AI deployment in Europe, contributing to improved patient care and accelerated diagnostic processes.
Key Questions Addressed in the Report:
What is the total CAGR expected to be recorded for the AI in Healthcare market during 2024-2029?
The global AI in Healthcare market share is expected to record a CAGR of 48.1% from 2024-2029.
Which regions are expected to pose significant demand for the AI in Healthcare market from 2024-2029?
North America & Asia Pacific are expected to pose significant demand from 2024 to 2029. Major economies such as US, Canada, China, Japan, and India are expected to have a high potential for the future growth of the market.
What are the major market opportunities for the AI in Healthcare market?
Growing potential of Al-based tools for elderly care, increasing focus on developing human-aware Al systems, and Rising potential of Al technology in genomics, drug discovery, and imaging & and diagnostics are the significant market opportunities in the AI in Healthcare market during the forecast period.
Which are the significant players operating in the AI in Healthcare market?
Key players operating in the AI in Healthcare market are Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers AG (Germany), Intel Corporation (US), NVIDIA Corporation (US), Google Inc. (US), GE HealthCare Technologies Inc. (US), Oracle (US), and Johnson & Johnson Services, Inc. (US).
What are the major applications of the AI in Healthcare market?
Patient data & risk analysis, in-patient care & hospital management, medical imaging & diagnostics, lifestyle management & remote patient monitoring, virtual assistants, drug discovery, research, healthcare assistance robots, precision medicine, emergency room & surgery, wearables, mental health, and cybersecurity are the major applications of AI in Healthcare market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
- 5.1 INTRODUCTION
-
5.2 MARKET DYNAMICSDRIVERS- Exponential growth in data volume and complexity due to surging adoption of digital technologies- Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases- Rapid proliferation of AI in healthcare sector- Growing need for improvised healthcare servicesRESTRAINTS- Reluctance among medical practitioners to adopt AI-based technologies- Shortage of skilled AI professionals handling AI-powered solutions- Lack of standardized frameworks for AL and ML technologiesOPPORTUNITIES- Increasing use of AI-powered solutions in elderly care- Increasing focus on developing human-aware AI systems- Rising use of technology in pharmaceuticals industry- Strategic partnerships and collaborations among healthcare companies and AI technology providersCHALLENGES- Inaccurate predictions due to scarcity of high-quality healthcare data- Concerns regarding data privacy- Lack of interoperability between AI solutions offered by different vendors
- 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
-
5.4 PRICING ANALYSISAVERAGE SELLING PRICE (ASP) TREND OF COMPONENTS OFFERED BY KEY PLAYERS, 2020–2029AVERAGE SELLING PRICE (ASP) TREND OF PROCESSOR COMPONENTS, BY REGION, 2020–2029
- 5.5 VALUE CHAIN ANALYSIS
- 5.6 ECOSYSTEM MAPPING
-
5.7 TECHNOLOGY ANALYSISCLOUD COMPUTINGCLOUD GPUGENERATIVE AICLOUD-BASED PACSMULTI-CLOUD
- 5.8 PATENT ANALYSIS
- 5.9 TRADE ANALYSIS
- 5.10 KEY CONFERENCES AND EVENTS, 2024–2025
-
5.11 CASE STUDY ANALYSISBIOBEAT LAUNCHED HOME-BASED REMOTE PATIENT MONITORING KIT DURING PEAK WAVE OF COVID-19MICROSOFT COLLABORATED WITH CLEVELAND CLINIC TO APPLY PREDICTIVE AND ADVANCED ANALYTICS TO IDENTIFY POTENTIAL AT-RISK PATIENTS UNDER ICU CARETGEN COLLABORATED WITH INTEL CORPORATION AND DELL TECHNOLOGIES TO ASSIST PHYSICIANS AND RESEARCHERS ACCELERATE DIAGNOSIS AND TREATMENT AT LOWER COSTINSILICO DEVELOPED ML-POWERED TOOLS FOR DRUG IDENTIFICATION AND CHEMISTRY42 FOR NOVEL COMPOUND DESIGNGE HEALTHCARE IMPROVED PATIENT OUTCOMES BY REDUCING WORKFLOW PROCESSING TIME USING MEDICAL IMAGING DATA
-
5.12 TARIFFS, STANDARDS, AND REGULATORY LANDSCAPEREGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONSSTANDARDS- ISO 22399:2020- IEC 62366:2015- Health Insurance Portability and Accountability Act (HIPAA)- EU General Data Protection Regulation (GDPR)- Fast Healthcare Interoperability Resources (HL7 FHIR)- Medical Device Regulation- World Health Organization Artificial intelligence for Health Guide- Algorithmic Justice League framework for assessing AI in healthcareGOVERNMENT REGULATIONS- US- Europe- China- Japan- India
-
5.13 PORTER’S FIVE FORCES ANALYSISTHREAT OF NEW ENTRANTSTHREAT OF SUBSTITUTESBARGAINING POWER OF SUPPLIERSBARGAINING POWER OF BUYERSINTENSITY OF COMPETITIVE RIVALRY
-
5.14 KEY STAKEHOLDERS AND BUYING CRITERIAKEY STAKEHOLDERS IN BUYING PROCESSBUYING CRITERIA
- 6.1 INTRODUCTION
-
6.2 HARDWAREPROCESSOR- Need for real-time processing of patient data to boost demand- MPUs/CPUs- GPUs- FPGAs- ASICsMEMORY- Increasing demand for real-time medical image analysis and diagnosis support systems to drive marketNETWORK- Growing need for remote patient monitoring and precision medicine to foster segmental growth
-
6.3 SOFTWAREAI SOLUTION- Integration of non-procedural languages into AI solutions to accelerate segmental growth- On-premises- CloudAI PLATFORM- Increasing applications in development of toolkits for healthcare solutions to drive market- Machine learning framework- Application program interface
-
6.4 SERVICESDEPLOYMENT & INTEGRATION- Enhanced patient care along with streamlines workflows to drive demandSUPPORT & MAINTENANCE- Need to evaluate performance and maintain operational stability to drive market
- 7.1 INTRODUCTION
-
7.2 MACHINE LEARNINGDEEP LEARNING- Rising applications in voice recognition, fraud detection, and recommendation engines to drive marketSUPERVISED LEARNING- Contribution to clinical decision-making and enhancing personalized medications to boost demandREINFORCEMENT LEARNING- Enhanced diagnostic accuracy in medical imaging analysis to fuel market growthUNSUPERVISED LEARNING- Ability to uncover hidden patterns and handle unlabeled data challenges to boost demandOTHERS
-
7.3 NATURAL LANGUAGE PROCESSINGIVR- Enhanced operational efficiency and optimized clinical support to drive marketOCR- Reduced errors in data entry and streamlined administrative processes to spur demandPATTERN AND IMAGE RECOGNITION- Optimized therapeutic outcomes and development of personal medication to foster segmental growthAUTO CODING- Contribution to cost-saving and optimization of coding processes to drive marketCLASSIFICATION AND CATEGORIZATION- Accurate prediction of disease outcomes to boost demandTEXT ANALYTICS- Significant contribution to drug discovery by examining extensive datasets of scientific literature to boost demandSPEECH ANALYTICS- Contribution to sentiment analysis by assessing tone of patient conversations to boost demand
-
7.4 CONTEXT-AWARE COMPUTINGDEVICE CONTEXT- Ability to offer comprehensive view of patient data to boost demandUSER CONTEXT- Better predictive analysis for disease prevention to foster segmental growthPHYSICAL CONTEXT- Ability to address individualized needs based on surrounding environment to boost market
-
7.5 COMPUTER VISIONENHANCED PRECISION WITH 3D VISUALIZATIONS AND PERSONALIZED PROCEDURES TO FOSTER SEGMENTAL GROWTH
- 8.1 INTRODUCTION
-
8.2 PATIENT DATA & RISK ANALYSISCONVERGENCE OF ML AND NLP TO OFFER LUCRATIVE GROWTH OPPORTUNITIES FOR PLAYERS
-
8.3 IN-PATIENT CARE & HOSPITAL MANAGEMENTEASE OF PATIENT SCHEDULING WITH CHATBOTS AND VIRTUAL ASSISTANTS TO DRIVE MARKET
-
8.4 MEDICAL IMAGING & DIAGNOSTICSACCESSIBILITY IN MEDICAL IMAGING AND WORKFLOW OPTIMIZATION TO FOSTER SEGMENTAL GROWTH
-
8.5 LIFESTYLE MANAGEMENT & REMOTE PATIENT MONITORINGENHANCED PATIENT COMPLIANCE THROUGH BEHAVIORAL ANALYSIS TO BOOST DEMAND
-
8.6 VIRTUAL ASSISTANTSABILITY TO OFFER SIMPLIFIED COMPLEX MEDICAL INFORMATION TO DRIVE MARKET
-
8.7 DRUG DISCOVERYACCELERATED IDENTIFICATION OF POTENTIAL DRUG CANDIDATES TO BOOST DEMAND
-
8.8 RESEARCHGROWING IMPORTANCE IN ANALYSIS OF SEQUENCE AND FUNCTIONAL PATTERNS FROM SEQUENCE DATABASES TO ACCELERATE DEMAND
-
8.9 HEALTHCARE ASSISTANCE ROBOTSUSE TO REVOLUTIONIZE PATIENT CARE BY STREAMLINING TASKS AND ENABLING REAL-TIME DATA ANALYSIS AND ENHANCE HEALTHCARE EXPERIENCES TO DRIVE MARKET
-
8.10 PRECISION MEDICINESPERSONALIZED HEALTHCARE BY STREAMLINING CLINICAL TRIALS TO ACCELERATE DEMAND
-
8.11 EMERGENCY ROOMS & SURGERIESQUICK IDENTIFICATION OF LIFE-THREATENING PATHOLOGIES TO FOSTER SEGMENTAL GROWTH
-
8.12 WEARABLESPERSONALIZED TREATMENT STRATEGIES AND REAL-TIME INSIGHTS TO BOOST DEMAND
-
8.13 MENTAL HEALTHPRESSING NEED TO DETECT DEPRESSION AND IDENTIFY SUICIDE RISKS THROUGH TEXT ANALYSIS TO DRIVE MARKET
-
8.14 CYBERSECURITYPREVENTION OF INFILTRATION ATTEMPTS AND ENHANCED SPEED OF THREAT DETECTION TO BOOST DEMAND
- 9.1 INTRODUCTION
-
9.2 HOSPITALS & HEALTHCARE PROVIDERSINCREASING USE IN MINING MEDICAL DATA AND STUDYING GENOMICS-BASED DATA FOR PERSONALIZED MEDICINE TO BOOST MARKET GROWTH
-
9.3 PATIENTSRISE IN USE OF AI IN MENTAL HEALTH SUPPORT APPLICATIONS THROUGH CHATBOTS AND VIRTUAL THERAPISTS TO BOOST MARKET GROWTH
-
9.4 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIESGROWING PARTNERSHIPS AMONG PLAYERS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS
-
9.5 HEALTHCARE PAYERSFAST AND ACCURATE CLAIM PROCESSING AND ENHANCED FRAUD DETECTION BENEFITS TO BOOST DEMAND
- 9.6 OTHERS
- 10.1 INTRODUCTION
-
10.2 NORTH AMERICANORTH AMERICA: RECESSION IMPACTUS- High healthcare spending in US to drive marketCANADA- Government-led initiatives to support deployment of AI in healthcare sector to boost demandMEXICO- Increasing private sector investments in AI healthcare technologies to drive market
-
10.3 EUROPEEUROPE: RECESSION IMPACTGERMANY- Rising healthcare data generation to drive marketUK- Targeted treatment with increased success rates to fuel market growthFRANCE- Focus on telemedicine and chronic disease management to drive marketITALY- Rising geriatric population to drive marketSPAIN- Growing partnerships between technology firms and healthcare providers to boost demandREST OF EUROPE
-
10.4 ASIA PACIFICASIA PACIFIC: RECESSION IMPACTCHINA- Government-led measures to expedite integration of AI into healthcare sector to drive marketJAPAN- Increasing number of AI-driven start-ups manufacturing diagnostic and therapeutic tools to fuel market growthSOUTH KOREA- Increasing incidence of cancer to drive marketINDIA- Developing IT infrastructure and AI-friendly government initiatives to spur market growthREST OF ASIA PACIFIC
-
10.5 ROWROW: RECESSION IMPACTSOUTH AMERICA- High investments in healthcare IT to drive marketGCC- Rising focus on technological advancements in healthcare sector to drive marketREST OF MIDDLE EAST & AFRICA- Growing investments in information and communication technologies to boost demand
- 11.1 OVERVIEW
- 11.2 STRATEGIES ADOPTED BY MAJOR PLAYERS, 2020–2023
- 11.3 REVENUE ANALYSIS, 2019–2023
- 11.4 MARKET SHARE ANALYSIS, 2023
-
11.5 COMPANY EVALUATION MATRIX, 2023STARSEMERGING LEADERSPERVASIVE PLAYERSPARTICIPANTSCOMPANY FOOTPRINT
-
11.6 START-UP/SMALL AND MEDIUM-SIZED ENTERPRISE (SME) EVALUATION MATRIX, 2023PROGRESSIVE COMPANIESRESPONSIVE COMPANIESDYNAMIC COMPANIESSTARTING BLOCKSCOMPETITIVE BENCHMARKING
-
11.7 COMPETITIVE SCENARIOS AND TRENDSPRODUCT LAUNCHESDEALS
-
12.1 KEY PLAYERSKONINKLIJKE PHILIPS N.V.- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewMICROSOFT- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewSIEMENS HEALTHINEERS AG- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewINTEL CORPORATION- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewNVIDIA CORPORATION- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewGOOGLE INC.- Business overview- Products/Solutions/Services offered- Recent developmentsGE HEALTHCARE- Business overview- Products/Solutions/Services offered- Recent developmentsMEDTRONIC- Business overview- Products/Solutions/Services offered- Recent developmentsMICRON TECHNOLOGY, INC.- Business overview- Products/Solutions/Services offered- Recent developmentsAMAZON.COM, INC.- Business overview- Products/Solutions/Services offered- Recent developmentsORACLE- Business overview- Products/Solutions/Services offered- Recent developmentsJOHNSON & JOHNSON SERVICES, INC.- Business overview- Products/Solutions/Services offered- Recent developments
-
12.2 OTHER PLAYERSMERATIVEGENERAL VISION INC.CLOUDMEDXONCORA MEDICALENLITIC, INC.LUNIT INC.QURE.AITEMPUSCOTAFDNA INC.RECURSIONATOMWISE INC.VIRGIN PULSEBABYLON HEALTHCARE SERVICES LTDMDLIVE (EVERNORTH GROUP)STRYKERQVENTUSSWEETCHSIRONA MEDICAL, INC.GINGERBIOBEAT
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS
- TABLE 1 AVERAGE SELLING PRICE (ASP) OF PROCESSOR COMPONENTS OFFERED BY KEY PLAYERS
- TABLE 2 COMPANIES AND THEIR ROLES IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE ECOSYSTEM
- TABLE 3 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS
- TABLE 4 TOP PATENT OWNERS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET IN LAST 10 YEARS
- TABLE 5 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: LIST OF CONFERENCES AND EVENTS, 2024–2025
- TABLE 6 MFN TARIFF FOR HS CODE 854231-COMPLIANT PRODUCTS EXPORTED BY US, 2022
- TABLE 7 MFN TARIFF FOR HS CODE 854231-COMPLIANT PRODUCTS EXPORTED BY CHINA, 2022
- TABLE 8 MFN TARIFF FOR HS CODE 854231-COMPLIANT PRODUCTS EXPORTED BY GERMANY, 2022
- TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 12 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 13 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS
- TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
- TABLE 15 KEY BUYING CRITERIA FOR TOP THREE END USERS
- TABLE 16 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2020–2023 (USD MILLION)
- TABLE 17 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2024–2029 (USD MILLION)
- TABLE 18 HARDWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 19 HARDWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 20 HARDWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 21 HARDWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 22 PROCESSOR: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2020–2023 (MILLION UNITS)
- TABLE 23 PROCESSOR: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2024–2029 (MILLION UNITS)
- TABLE 24 PROCESSOR: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 25 PROCESSOR: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 26 CASE STUDY: PHILIPS COLLABORATED WITH INTEL CORPORATION TO OPTIMIZE AI INFERENCING HEALTHCARE WORKLOADS ON INTEL XEON SCALABLE PROCESSORS USING OPENVINO TOOLKIT
- TABLE 27 CASE STUDY: DEEPPHARMA PLATFORM, OFFERED BY INSILICO, EQUIPPED WITH ADVANCED DEEP LEARNING TECHNIQUES, HELPS ANALYZE MULTI-OMICS DATA AND TISSUE-SPECIFIC PATHWAY ACTIVATION PROFILES
- TABLE 28 CASE STUDY: INTEL CORPORATION, IN COLLABORATION WITH BROAD INSTITUTE, DEVELOPED BIGSTACK* 2.0 TO MEET EVOLVING DEMANDS OF GENOMICS RESEARCH
- TABLE 29 CASE STUDY: HUAWEI ASSISTED TOULOUSE UNIVERSITY HOSPITAL WITH OCEANSTOR ALL-FLASH SOLUTION THAT OFFERS LOW LATENCY AND SIMPLIFIED OPERATIONS AND MAINTENANCE MANAGEMENT
- TABLE 30 NETWORK: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 31 NETWORK: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 32 SOFTWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 33 SOFTWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 34 SOFTWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 35 SOFTWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 36 CASE STUDY: COGNIZANT LEVERAGED AZURE PLATFORM OF MICROSOFT AND DEVELOPED RESOLV, THAT EMPLOYS NATURAL LANGUAGE PROCESSING TO PROVIDE REAL-TIME RESPONSE TO ANALYTICAL QUERIES
- TABLE 37 SOFTWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR AI SOLUTIONS, BY DEPLOYMENT TYPE, 2020–2023 (USD MILLION)
- TABLE 38 SOFTWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR AI SOLUTIONS, BY DEPLOYMENT TYPE, 2024–2029 (USD MILLION)
- TABLE 39 CASE STUDY: GE HEALTHCARE ENHANCED ON-PREMISES CAPABILITY WITH SCYLLADB’S PROJECT ALTERNATOR
- TABLE 40 CASE STUDY: TAKEDA COLLABORATED WITH DELOITTE TO EMPLOY DEEP MINER TOOLKIT FOR RAPID DEVELOPMENT AND TESTING OF PREDICTIVE MODELS
- TABLE 41 CASE STUDY: CAYUGA MEDICAL CENTER SOUGHT SIMPLE CDI SOFTWARE SOLUTION TO IMPROVE WORKFLOWS AND REDUCE COSTS
- TABLE 42 SOFTWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR AI PLATFORMS, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 43 SOFTWARE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR AI PLATFORMS, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 44 SERVICES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 45 SERVICES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 46 SERVICES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 47 SERVICES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 48 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2023 (USD MILLION)
- TABLE 49 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION)
- TABLE 50 CASE STUDY: IN COLLABORATION WITH INTEL AND APOQLAR, THEBLUE.AI INTRODUCED BLUW.GDPR. EQUIPPED WITH ML ALGORITHMS ACCELERATED BY OPENVINO TOOLKIT
- TABLE 51 MACHINE LEARNING: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 52 MACHINE LEARNING: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 53 WINNING HEALTH TECHNOLOGY INTRODUCED AI MEDICAL IMAGING SOLUTION BASED ON AMAX DEEP LEARNING ALL-IN-ONE TO REDUCE OVERALL MODEL INFERENCE TIME FROM OVER 0.5 HOURS TO LESS THAN 2 MINUTES FOR AI-AIDED DIAGNOSTIC IMAGING OF PULMONARY NODULES
- TABLE 54 CASE STUDY: MARUTI TECHLABS ASSISTED UKHEALTH WITH ML MODEL FOR AUTOMATIC DATA EXTRACTION AND CLASSIFICATION
- TABLE 55 NATURAL LANGUAGE PROCESSING: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 56 NATURAL LANGUAGE PROCESSING: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 57 CONTEXT-AWARE COMPUTING: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 58 CONTEXT-AWARE COMPUTING: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 59 CASE STUDY: PUNKTUM COLLABORATED WITH MAYO CLINIC TO DEVELOP CUTTING-EDGE DEEP LEARNING-BASED MODEL FOCUSED ON COMPUTER VISION FOR ACCURATE CLASSIFICATION OF ISCHEMIC STROKE ORIGINS
- TABLE 60 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 61 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 62 CASE STUDY: MAYO CLINIC PARTNERED WITH GOOGLE TO IMPLEMENT AI MODELS AND ENHANCE PATIENT CARE
- TABLE 63 PATIENT DATA & RISK ANALYSIS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 64 PATIENT DATA & RISK ANALYSIS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 65 PATIENT DATA & RISK ANALYSIS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 66 PATIENT DATA & RISK ANALYSIS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 67 CASE STUDY: PROMINENT MULTISPECIALTY HOSPITAL EMPLOYED ADOBE XD TO PREVENT RESOURCE WASTAGE AND ENHANCE EFFICIENCY
- TABLE 68 IN-PATIENT CARE & HOSPITAL MANAGEMENT: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 69 IN-PATIENT CARE & HOSPITAL MANAGEMENT: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 70 IN-PATIENT CARE & HOSPITAL MANAGEMENT: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 71 IN-PATIENT CARE & HOSPITAL MANAGEMENT: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 72 CASE STUDY: PHILIPS TRANSFORMED HEALTHCARE WITH AWS-POWERED AI SOLUTIONS
- TABLE 73 MEDICAL IMAGING & DIAGNOSTICS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 74 MEDICAL IMAGING & DIAGNOSTICS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 75 MEDICAL IMAGING & DIAGNOSTICS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 76 MEDICAL IMAGING & DIAGNOSTICS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 77 LIFESTYLE MANAGEMENT & REMOTE PATIENT MONITORING: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 78 LIFESTYLE MANAGEMENT & REMOTE PATIENT MONITORING: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 79 LIFESTYLE MANAGEMENT & REMOTE PATIENT MONITORING: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 80 LIFESTYLE MANAGEMENT & REMOTE PATIENT MONITORING: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 81 CASE STUDY: OSF COLLABORATED WITH GYANT TO IMPLEMENT CLARE, AI VIRTUAL CARE NAVIGATION ASSISTANT, BOOSTING DIGITAL HEALTH TRANSFORMATION
- TABLE 82 VIRTUAL ASSISTANT: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 83 VIRTUAL ASSISTANT: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 84 VIRTUAL ASSISTANT: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 85 VIRTUAL ASSISTANT: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 86 CASE STUDY: AZOTHBIO UTILIZED RESCALE’S PLATFORM TO ENHANCE R&D AGILITY
- TABLE 87 DRUG DISCOVERY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 88 DRUG DISCOVERY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 89 DRUG DISCOVERY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 90 DRUG DISCOVERY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 91 RESEARCH: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 92 RESEARCH: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 93 RESEARCH: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 94 RESEARCH: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 95 HEALTHCARE ASSISTANCE ROBOTS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 96 HEALTHCARE ASSISTANCE ROBOTS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 97 HEALTHCARE ASSISTANCE ROBOTS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 98 HEALTHCARE ASSISTANCE ROBOTS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 99 PRECISION MEDICINE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 100 PRECISION MEDICINE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 101 PRECISION MEDICINE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 102 PRECISION MEDICINE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 103 EMERGENCY ROOMS & SURGERIES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 104 EMERGENCY ROOMS & SURGERIES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 105 EMERGENCY ROOMS & SURGERIES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 106 EMERGENCY ROOMS & SURGERIES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 107 CASE STUDY: KENSCI COLLABORATED WITH MICROSOFT TO ASSIST US NATIONAL GOVERNMENT IN IDENTIFYING PATIENTS WITH COPD
- TABLE 108 WEARABLES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 109 WEARABLES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 110 WEARABLES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 111 WEARABLES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 112 MENTAL HEALTH: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 113 MENTAL HEALTH: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 114 MENTAL HEALTH: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 115 MENTAL HEALTH: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 116 CASE STUDY: SNORKEL FLOW CREATED HIGH-ACCURACY ML MODELS TO OVERCOME HAND-LABELING CHALLENGES
- TABLE 117 CYBERSECURITY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 118 CYBERSECURITY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 119 CYBERSECURITY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 120 CYBERSECURITY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 121 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 122 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 123 CASE STUDY: UNIVERSITY COLLEGE LONDON, KING’S COLLEGE LONDON, AND NATIONAL HEALTH SERVICE COLLABORATION RESULTED IN DEVELOPMENT OF COGSTACK, THAT REVOLUTIONIZED HEALTHCARE DATA UTILIZATION
- TABLE 124 HOSPITALS & HEALTHCARE PROVIDERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 125 HOSPITALS & HEALTHCARE PROVIDERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 126 HOSPITALS & HEALTHCARE PROVIDERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 127 HOSPITALS & HEALTHCARE PROVIDERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 128 CASE STUDY: COGNIZANT PARTNERED WITH ONE OF CLIENTS TO ENHANCE CALLER SELF-SERVICE AND IMPROVE MEMBER EXPERIENCE METRICS
- TABLE 129 PATIENTS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 130 PATIENTS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 131 PATIENTS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 132 PATIENTS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 133 CASE STUDY: AZURE MACHINE LEARNING-BASED INTELLIGENT SYSTEM ASSISTED LEADING PHARMA COMPANY TO AUTO-CLASSIFY PRODUCTS INTO MARKET-RELATED CATEGORIES THAT BOOSTED OPERATIONAL EFFICIENCY
- TABLE 134 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 135 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 136 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 137 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 138 HEALTHCARE PAYERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 139 HEALTHCARE PAYERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 140 HEALTHCARE PAYERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 141 HEALTHCARE PAYERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 142 OTHERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 143 OTHERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 144 OTHERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 145 OTHERS: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 146 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 147 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 148 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
- TABLE 149 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 150 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2020–2023 (USD MILLION)
- TABLE 151 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2024–2029 (USD MILLION)
- TABLE 152 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 153 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 154 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 155 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 156 US: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 157 US: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 158 CANADA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 159 CANADA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 160 MEXICO: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 161 MEXICO: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 162 EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
- TABLE 163 EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 164 EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2020–2023 (USD MILLION)
- TABLE 165 EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2024–2029 (USD MILLION)
- TABLE 166 EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 167 EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 168 EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 169 EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 170 GERMANY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 171 GERMANY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 172 UK: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 173 UK: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 174 FRANCE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 175 FRANCE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 176 ITALY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 177 ITALY: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 178 SPAIN: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 179 SPAIN: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 180 REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 181 REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 182 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
- TABLE 183 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 184 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2020–2023 (USD MILLION)
- TABLE 185 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2024–2029 (USD MILLION)
- TABLE 186 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 187 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 188 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 189 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 190 CHINA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 191 CHINA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 192 JAPAN: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 193 JAPAN: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 194 SOUTH KOREA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 195 SOUTH KOREA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 196 INDIA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 197 INDIA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 198 REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 199 REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 200 ROW: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 201 ROW: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 202 ROW: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2020–2023 (USD MILLION)
- TABLE 203 ROW: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2024–2029 (USD MILLION)
- TABLE 204 ROW: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 205 ROW: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 206 ROW: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 207 ROW: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 208 SOUTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 209 SOUTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 210 GCC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 211 GCC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 212 REST OF MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 213 REST OF MEA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 214 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS, 2020–2023
- TABLE 215 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE ANALYSIS, 2023
- TABLE 216 OVERALL COMPANY FOOTPRINT
- TABLE 217 COMPANY OFFERING FOOTPRINT
- TABLE 218 COMPANY END USER FOOTPRINT
- TABLE 219 COMPANY REGION FOOTPRINT
- TABLE 220 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: LIST OF KEY START-UPS/SMES
- TABLE 221 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
- TABLE 222 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PRODUCT LAUNCHES, 2020–2023
- TABLE 223 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: DEALS, 2020–2023
- TABLE 224 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
- TABLE 225 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 226 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
- TABLE 227 KONINKLIJKE PHILIPS N.V.: DEALS
- TABLE 228 KONINKLIJKE PHILIPS N.V.: OTHERS
- TABLE 229 MICROSOFT: COMPANY OVERVIEW
- TABLE 230 MICROSOFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 231 MICROSOFT: PRODUCT LAUNCHES
- TABLE 232 MICROSOFT: DEALS
- TABLE 233 MICROSOFT: OTHERS
- TABLE 234 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
- TABLE 235 SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 236 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES
- TABLE 237 SIEMENS HEALTHINEERS AG: DEALS
- TABLE 238 SIEMENS HEALTHINEERS AG: OTHERS
- TABLE 239 INTEL CORPORATION: COMPANY OVERVIEW
- TABLE 240 INTEL CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 241 INTEL CORPORATION: PRODUCT LAUNCHES
- TABLE 242 INTEL CORPORATION: DEALS
- TABLE 243 INTEL CORPORATION: OTHERS
- TABLE 244 NVIDIA CORPORATION: COMPANY OVERVIEW
- TABLE 245 NVIDIA CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 246 NVIDIA CORPORATION: PRODUCT LAUNCHES
- TABLE 247 NVIDIA CORPORATION: DEALS
- TABLE 248 NVIDIA CORPORATION: OTHERS
- TABLE 249 GOOGLE INC.: COMPANY OVERVIEW
- TABLE 250 GOOGLE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 251 GOOGLE INC.: PRODUCT LAUNCHES
- TABLE 252 GOOGLE INC.: DEALS
- TABLE 253 GOOGLE INC.: OTHERS
- TABLE 254 GE HEALTHCARE: COMPANY OVERVIEW
- TABLE 255 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 256 GE HEALTHCARE: PRODUCT LAUNCHES
- TABLE 257 GE HEALTHCARE: DEALS
- TABLE 258 MEDTRONIC: COMPANY OVERVIEW
- TABLE 259 MEDTRONIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 260 MEDTRONIC: DEALS
- TABLE 261 MICRON TECHNOLOGY, INC.: COMPANY OVERVIEW
- TABLE 262 MICRON TECHNOLOGY, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 263 MICRON TECHNOLOGY, INC: .PRODUCT LAUNCHES
- TABLE 264 MICRON TECHNOLOGY, INC.: DEALS
- TABLE 265 AMAZON.COM, INC.: COMPANY OVERVIEW
- TABLE 266 AMAZON.COM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 267 AMAZON.COM, INC.: PRODUCT LAUNCHES
- TABLE 268 AMAZON.COM, INC.: DEALS
- TABLE 269 ORACLE: COMPANY OVERVIEW
- TABLE 270 ORACLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 271 ORACLE: PRODUCT LAUNCHES
- TABLE 272 ORACLE: DEALS
- TABLE 273 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
- TABLE 274 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 275 JOHNSON & JOHNSON SERVICES, INC.: DEALS
- FIGURE 1 GDP GROWTH PROJECTION DATA FOR MAJOR ECONOMIES, 2021–2023
- FIGURE 2 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: RESEARCH DESIGN
- FIGURE 3 RESEARCH FLOW: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE ESTIMATION
- FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE): REVENUE GENERATED BY COMPANIES FROM ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
- FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
- FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (DEMAND SIDE): REVENUE GENERATED FROM ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER
- FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
- FIGURE 8 DATA TRIANGULATION
- FIGURE 9 SOFTWARE SEGMENT TO HOLD LARGEST MARKET SHARE IN 2029
- FIGURE 10 MACHINE LEARNING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
- FIGURE 11 PATIENTS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 12 MEDICAL IMAGING & DIAGNOSTICS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 13 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE OF GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET IN 2023
- FIGURE 14 INCREASING ADOPTION OF AI-BASED TOOLS IN HEALTHCARE FACILITIES TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS
- FIGURE 15 SOFTWARE SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
- FIGURE 16 MACHINE LEARNING TECHNOLOGY TO COMMAND MARKET FROM 2023 TO 2029
- FIGURE 17 HOSPITALS & HEALTHCARE PROVIDERS SEGMENT TO LEAD MARKET THROUGHOUT FORECAST PERIOD
- FIGURE 18 MEDICAL IMAGING & DIAGNOSTICS SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
- FIGURE 19 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET IN MEXICO TO GROW AT HIGHEST CAGR FROM 2024 TO 2029
- FIGURE 20 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 21 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: DRIVERS AND THEIR IMPACT
- FIGURE 22 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: RESTRAINTS AND THEIR IMPACT
- FIGURE 23 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: OPPORTUNITIES AND THEIR IMPACT
- FIGURE 24 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: CHALLENGES AND THEIR IMPACT
- FIGURE 25 DATA BREACHES IN HEALTHCARE SECTOR, 2019–2023
- FIGURE 26 CHALLENGES ASSOCIATED WITH HEALTHCARE DATA INTEROPERABILITY
- FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
- FIGURE 28 AVERAGE SELLING PRICE (ASP) OF PROCESSOR COMPONENTS OFFERED BY KEY PLAYERS
- FIGURE 29 AVERAGE SELLING PRICE (ASP) TREND OF PROCESSOR COMPONENTS, BY REGION, 2020–2029
- FIGURE 30 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS
- FIGURE 31 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: ECOSYSTEM MAPPING
- FIGURE 32 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PATENTS GRANTED, 2013–2023
- FIGURE 33 TOP 10 PATENT OWNERS IN LAST 10 YEARS, 2013–2023
- FIGURE 34 IMPORT DATA FOR HS CODE 854231-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)
- FIGURE 35 EXPORT DATA FOR HS CODE 854231-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)
- FIGURE 36 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS
- FIGURE 37 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
- FIGURE 38 KEY BUYING CRITERIA FOR TOP THREE END USERS
- FIGURE 39 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING
- FIGURE 40 SOFTWARE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
- FIGURE 41 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY
- FIGURE 42 MACHINE LEARNING TECHNOLOGY TO LEAD MARKET DURING FORECAST PERIOD
- FIGURE 43 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION
- FIGURE 44 MEDICAL IMAGING & DIAGNOSTICS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2029
- FIGURE 45 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER
- FIGURE 46 HOSPITALS & HEALTHCARE PROVIDERS TO HOLD LARGEST MARKET SHARE IN 2029
- FIGURE 47 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 48 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SNAPSHOT
- FIGURE 49 US TO DOMINATE NORTH AMERICAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET IN 2029
- FIGURE 50 EUROPE: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SNAPSHOT
- FIGURE 51 REST OF EUROPE TO EXHIBIT HIGHEST CAGR IN EUROPEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET DURING FORECAST PERIOD
- FIGURE 52 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SNAPSHOT
- FIGURE 53 CHINA TO EXHIBIT HIGHEST CAGR IN ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET DURING FORECAST PERIOD
- FIGURE 54 ROW: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SNAPSHOT
- FIGURE 55 SOUTH AMERICA TO DOMINATE ROW MARKET IN 2029
- FIGURE 56 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2019–2023
- FIGURE 57 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE ANALYSIS, 2023
- FIGURE 58 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX, 2023
- FIGURE 59 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: START-UP/SME EVALUATION MATRIX, 2023
- FIGURE 60 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
- FIGURE 61 MICROSOFT: COMPANY SNAPSHOT
- FIGURE 62 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
- FIGURE 63 INTEL CORPORATION: COMPANY SNAPSHOT
- FIGURE 64 NVIDIA CORPORATION: COMPANY SNAPSHOT
- FIGURE 65 GOOGLE INC.: COMPANY SNAPSHOT
- FIGURE 66 GE HEALTHCARE: COMPANY SNAPSHOT
- FIGURE 67 MEDTRONIC: COMPANY SNAPSHOT
- FIGURE 68 MICRON TECHNOLOGY, INC.: COMPANY SNAPSHOT
- FIGURE 69 AMAZON.COM, INC.: COMPANY SNAPSHOT
- FIGURE 70 ORACLE: COMPANY SNAPSHOT
- FIGURE 71 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
The research study involved the extensive use of secondary sources, directories, and databases (annual reports or presentations of companies, industry association publications, directories, technical handbooks, World Economic Outlook (WEO), trade websites, Hoovers, Bloomberg Businessweek, Factiva, and OneSource) to identify and collect information useful for this technical, market-oriented, and commercial study of the AI in Healthcare market. Primary sources mainly comprise several experts from the core and related industries, along with preferred suppliers, manufacturers, distributors, service providers, system providers, technology developers, alliances, and standards and certification organizations related to various phases of this industry’s value chain.
Secondary Research
Various secondary sources have been referred to in the secondary research process for identifying and collecting information important for this study. The secondary sources include annual reports, press releases, and investor presentations of companies; white papers; journals and certified publications; and articles from recognized authors, websites, directories, and databases. Secondary research has been conducted to obtain key information about the industry’s supply chain, market’s value chain, the total pool of key players, industry segmentation according to the industry trends (to the bottom-most level), geographic markets, and key developments from both market- and technology-oriented perspectives. The secondary data has been collected and analyzed to determine the overall market size, further validated by primary research.
Primary Research
In the primary research process, various primary sources from the supply and demand sides have been interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts, such as CEOs, vice presidents, marketing directors, technology & innovation directors, and related key executives from key companies and organizations operating in the AI in Healthcare market size across four major regions: North America, Europe, Asia Pacific, and RoW (South America, GCC, and Rest of MEA). Primary data has been collected through questionnaires, e-mails, and telephonic interviews. Approximately 40% and 60% of primary interviews have been conducted from the demand and supply sides, respectively.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
In the complete market engineering process, both top-down and bottom-up approaches have been used along with several data triangulation methods to perform market estimation and forecasting for the overall market segments and subsegments listed in this report. Key players in the market have been identified through secondary research, and their market shares in the respective regions have been determined through primary and secondary research. This entire procedure includes the study of annual and financial reports of the top market players and extensive interviews for key insights (quantitative and qualitative) with industry experts (CEOs, VPs, directors, and marketing executives).
In this approach, important players, such Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers (Germany), Intel Corporation (US), and NVIDIA Corporation (US) have been identified. After confirming these companies through primary interviews with industry experts, their total revenue has been estimated by referring to annual reports, SEC filings, and paid databases. Revenues of these companies pertaining to the business units (Bus) that offer AI in Healthcare have been identified through similar sources. Industry experts have reconfirmed these revenues through primary interviews.
AI in Healthcare Market: Bottom-Up Approach
The bottom-up approach has been employed to arrive at the overall size of the AI in Healthcare market from the revenues of key players and their share in the market.
AI in Healthcare Market: Top-Down Approach
In the top-down approach, the overall market size has been used to estimate the size of the individual markets (mentioned in the market segmentation) through percentage splits from secondary and primary research. The most appropriate immediate parent market size has been used to implement the top-down approach to calculate the market size of specific segments. The top-down approach has been implemented for the data extracted from the secondary research to validate the market size obtained.
Each company’s market share has been estimated to verify the revenue shares used earlier in the supply-side approach. The overall parent market size and individual market sizes were determined and confirmed in this study by the data triangulation method and the validation of data through primaries. The data triangulation method used in this study is explained in the next section.
Data Triangulation
After arriving at the overall market size from the market size estimation process explained earlier, the total market was split into several segments and subsegments. Data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the AI in healthcare market has been validated using both top-down and bottom-up approaches.
Market Definition
AI in Healthcare harnesses artificial intelligence's power to transform healthcare delivery and patient outcomes. It utilizes sophisticated machine learning, NLP, context-aware computing, and computer vision technologies to analyze massive amounts of medical data, enabling early disease detection, personalized treatment plans, enhanced clinical decision-making, and streamlined administrative processes.
The ecosystem of the AI in healthcare market comprises hardware providers, software providers, cloud service providers, AI solution providers, and end users of AI in healthcare. This industry is competitive and diversified, with over 30 companies competing across its value chain to sustain their position and increase their share in the market. The market is expected to grow significantly in the coming years due to the increasing use of large and complex datasets in hospitals, biotechnology, and pharmaceutical companies.
Key Stakeholders
- Semiconductor companies
- Technology providers
- Universities and research organizations
- Hospitals and healthcare payers
- System integrators
- AI solution providers
- AI platform providers
- Cloud service providers
- AI system providers
- Medical research and biotechnology companies
- Investors and venture capitalists
- Manufacturers and individuals implementing AI technology in healthcare devices and systems
Report Objectives
- To describe and forecast the artificial intelligence (AI) in healthcare market size , in terms of value, by offering, technology, application, and end-user
-
To describe and forecast the AI in healthcare market, in terms of value, for four main regions—
North America, Europe, Asia Pacific, and the Rest of the World (RoW) - To forecast the size and market segments of the AI in Healthcare market by volume based on Processor hardware.
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To provide an ecosystem analysis, case study analysis, patent analysis, technology analysis, ASP analysis, Porter’s Five Forces analysis, and regulations pertaining to the market.
- To provide a comprehensive overview of the value chain of the AI in healthcare market ecosystem
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
- To strategically profile the key players and comprehensively analyze their market shares and core competencies.
- To analyze the opportunities in the market for stakeholders and describe the competitive landscape of the market.
- To analyze competitive developments such as collaborations, agreements, partnerships, product developments, and research and development (R&D) in the market.
- To analyze the impact of the recession on the AI in Healthcare market size .
Available Customizations
With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 7)
Growth opportunities and latent adjacency in Artificial Intelligence (AI) in Healthcare Market
Interested about how AI will change the treatment process and its benefits.
I was going through the ToC of AI in Healthcare market, I would like to understand, what are the requirements to perform in the fields of AI?
I was going through the ToC of AI in Healthcare market, I would like to understand, what are the requirements to perform in the fields of AI?
We have specific interests in global AI in healthcare market and the US AI in healthcare market. Any further details related to market size of AI for early disease detection (for global and USA) would be appreciated.
I am looking to purchase this report to see the implications of AI on the workforce in Norway.
I am interested in understanding the market size and related insights on computer-assisted physician documentation (CAPD), clinical documentation improvement (CDI), computer-assisted coding (CAC), ambient voice and voice assistants, NLP, and machine learning for clinical, operational, and financial healthcare scenarios in AI in healthcare.
I am an automation enthusiast and would like to understand the impact of AI in healthcare. Could you provide me some brochure and sample to get into details.
I am conducting a research project on AI in healthcare as a part of my MHA/MBA marketing course. Could you share some relevant information in the form of sample brochure and estimated cost of the report, post discount mentioned on the website?
We are redeveloping our chart for Artificial Intelligence in Healthcare Market. Does your report covers regional market insights.